LCG
WGS icon

Lisanti Capital Growth’s GeneDx Holdings WGS Stock Holding History

Lisanti Capital Growth’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,128
Closed -$5.35M – 150
2025
Q4 		$5.35M Sell
41,128
-15,495
-27% -$2.13M 1.27% 27
2025
Q3 		$6.1M Buy
56,623
+8
+0% +$872 1.49% 17
2025
Q2 		$5.23M Buy
56,615
+27,180
+92% +$2.13M 1.45% 21
2025
Q1 		$2.61M Sell
29,435
-38,465
-57% -$3.34M 0.78% 56
2024
Q4 		$5.22M Buy
67,900
+31,285
+85% +$2.19M 1.26% 34
2024
Q3 		$1.55M Buy
+36,615
New +$1.24M 0.39% 93

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Lisanti Capital Growth's WGS Position: Q1 2026 in Review

Lisanti Capital Growth sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 41,128 shares — an estimated $5.35M sold.

Lisanti Capital Growth first reported a position in WGS in Q3 2024 and held it in 6 quarters. The position peaked at $6.1M in Q3 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Lisanti Capital Growth reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Lisanti Capital Growth sold 41,128 GeneDx Holdings shares in Q1 2026, an estimated $5.35M.
  • Lisanti Capital Growth first reported a position in GeneDx Holdings in Q3 2024 and held it in 6 quarters.
  • Lisanti Capital Growth's GeneDx Holdings position peaked at $6.1M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Lisanti Capital Growth's 13F filing for Q1 2026, filed 7 May 2026.